Humanin Trifluoroacetate
CAS: 330936-69-1
Ref. 3D-FH77866
1mg | Descontinuado | ||
5mg | Descontinuado | ||
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado | ||
100mg | Descontinuado |
Informação sobre produto
- 1-24-Proteinhumanin (human)
- 188: PN: US20090053203 SEQID: 188 claimed protein
- 1: PN: JP2006213632SEQID: 1 claimed protein
- 1:PN: WO2009040017 PAGE: 98 claimed protein
- 2: PN: WO03045988 SEQID: 2 claimedsequence
- 317: PN:WO2005051988 SEQID: 317 claimed protein
- 369: PN: WO0176532 SEQID: 91 claimedprotein
- 48: PN: WO0181361 SEQID: 47 claimed protein
- 4: PN: WO2008115525 SEQID: 188claimed protein
- 60: PN:WO2008058016 SEQID: 60 claimed protein
- Ver mais sinónimos
- 7: PN: WO0121786 SEQID: 5 claimedsequence
- Humanin
- Humanin(human clone CG202524-01)
- Protein (human clone 1 humanin sequence homolog)
- Protein Humanin (human)
- T lymphocyte activation-associated protein PRO86272(human)
Humanin is a hormone-like peptide that has been shown to have potent apoptosis-inducing activity against cancer tissues and hyperproliferative diseases. It binds to growth factor β1, which prevents the binding of the ligand to its receptors on cells. The binding of humanin to growth factor β1 inhibits the activation of transcription factors, preventing proliferation and cell cycle progression. Humanin also interacts with mitochondrial functions, inducing mitochondrial dysfunction and death in cancer cells. This process may be mediated by the induction of reactive oxygen species (ROS) and/or activation of caspases.